HomeIMNM • NASDAQ
add
Immunome Inc
Previous close
$14.10
Day range
$13.94 - $16.40
Year range
$5.15 - $16.40
Market cap
1.43B USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 4.02M | 69.84% |
Operating expense | 48.26M | 37.81% |
Net income | -43.40M | -20.14% |
Net profit margin | -1.08K | 29.26% |
Earnings per share | -0.50 | 16.67% |
EBITDA | -45.84M | -38.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 268.04M | -3.71% |
Total assets | 296.29M | 0.03% |
Total liabilities | 27.02M | -36.24% |
Total equity | 269.27M | — |
Shares outstanding | 87.05M | — |
Price to book | 4.56 | — |
Return on assets | -36.37% | — |
Return on capital | -39.70% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -43.40M | -20.14% |
Cash from operations | -49.40M | -111.14% |
Cash from investing | -64.17M | 21.44% |
Cash from financing | -55.00K | -107.93% |
Net change in cash | -113.63M | -8.85% |
Free cash flow | -35.39M | -84.20% |
About
Founded
2006
Headquarters
Website
Employees
155